Galsulfase

加硫酶

Report date: 2022/02/09 09:55:41
First In Class

Base Information

Drug NameGalsulfase
Drug Alias Namegalsulfasa戈硫酯酶伽硫酸酯酶recombinant human N-acetylgalactosamine-4-sulfataseRecombinant human arylsulfatase B +[11] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionGlycosaminoglycan degraders
TargetsGlycosaminoglycan
Therapy Area/IndicationsMucopolysaccharidosis VI
Global Approved IndicationsMucopolysaccharidosis VI
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/05/31
Country/TerritoryUnited StatesEUJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnges MgBiomarin Pharmaceutical IncBiomarin International Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis VI
Inactive IndicationsN/A

Other Information

ATC CodeA16AB08
Related LinksWikipediaDrugBankKEGG